Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1771 AL 1785

[Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB]

Sakakibara R.

Rinsho Shinkeigaku. 2013;53(11):1389-92. doi: 10.5692/clinicalneurol.53.1389.

[Perioperative approach to restless legs syndrome]

Bartelke F, Pfister R, Kämmerer W.

Anaesthesist. 2013 Dec;62(12):1023-33. doi: 10.1007/s00101-013-2267-6.

Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs

Meltzer HY, Roth BL.

J Clin Invest. 2013 Dec;123(12):4986-91. doi: 10.1172/JCI70678. Epub 2013 Dec 2.

[Atrial fibrillation in patient with concealed Wolff-Parkinson-White syndrome]

Sredniawa B, Mitręga K, Kowalski O, Lenarczyk R, Pluta S, Musialik-Łydka A, Kalarus Z.

Kardiol Pol. 2013;71(11):1204-6. doi: 10.5603/KP.2013.0306.

A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases

Wright JW, Kawas LH, Harding JW.

Front Endocrinol (Lausanne). 2013 Oct 25;4:158. doi: 10.3389/fendo.2013.00158.

[Comparison of cognitive functions and neuropsychiatric symptoms between patients with Parkinson's disease dementia and Alzheimer's disease]

Tang Y, Ji XJ, Xing Y, Zuo XM, Zhou AH, Jia JP.

Zhonghua Yi Xue Za Zhi. 2013 Aug 20;93(31):2459-62.

[Morphometric parameters of the neurodegenerative process in Parkinson's disease and chronic cerebral ischemia]

Bogdanov RR, Manannikova EI, Abrabenko AS, Maratkanova TV, Kotov SV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(10):40-4.

[Kinesitherapy is a basic element of non-pharmacological treatment of Parkinson's disease]

Kamakinova AB, Golubev VL.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(10):69-73.

Oral rehabilitation of a Parkinson's patient: A case report

Singh Y, Saini M, Garg N.

World J Clin Cases. 2013 Apr 16;1(1):67-70. doi: 10.12998/wjcc.v1.i1.67.

The G2019S LRRK2 mutation: another morbid burden for Ashkenazi Jews may provide new insights on sporadic Parkinson's disease

Melamed E.

Mov Disord. 2013 Dec;28(14):1912-4. doi: 10.1002/mds.25728. Epub 2013 Dec 4.

RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis

Heman-Ackah SM, Hallegger M, Rao MS, Wood MJ.

Front Mol Neurosci. 2013 Nov 20;6:40. doi: 10.3389/fnmol.2013.00040.

Efficacy of modafinil on fatigue and excessive daytime sleepiness associated with neurological disorders: a systematic review and meta-analysis

Sheng P, Hou L, Wang X, Wang X, Huang C, Yu M, Han X, Dong Y.

PLoS One. 2013 Dec 3;8(12):e81802. doi: 10.1371/journal.pone.0081802. eCollection 2013.

Molecular chaperones and protein folding as therapeutic targets in Parkinson's disease and other synucleinopathies

Ebrahimi-Fakhari D, Saidi LJ, Wahlster L.

Acta Neuropathol Commun. 2013 Dec 5;1(1):79. doi: 10.1186/2051-5960-1-79.

[Effect of PD-WEBB training on balance impairment and falls in people with Parkinson's disease]

Gu S, Song Z, Fan X, Chen R, Zheng W, Yan W.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Nov;38(11):1172-6. doi: 10.3969/j.issn.1672-7347.2013.11.015.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias